BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30537722)

  • 1. Expression Levels of microRNAs miR-93 and miR-200a in Pancreatic Adenocarcinoma with Special Reference to Differentiation and Relapse-Free Survival.
    Karihtala P; Porvari K; Soini Y; Eskelinen M; Juvonen P; Haapasaari KM
    Oncology; 2019; 96(3):164-170. PubMed ID: 30537722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
    Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
    J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis.
    Yang JJ; Tao H; Hu W; Liu LP; Shi KH; Deng ZY; Li J
    Cell Signal; 2014 Nov; 26(11):2381-9. PubMed ID: 25049078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
    Sun X; Zuo H; Liu C; Yang Y
    Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.
    Liu M; Hu C; Xu Q; Chen L; Ma K; Xu N; Zhu H
    Biosci Rep; 2015 Sep; 35(5):. PubMed ID: 26341629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells.
    Eades G; Yang M; Yao Y; Zhang Y; Zhou Q
    J Biol Chem; 2011 Nov; 286(47):40725-33. PubMed ID: 21926171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C66 ameliorates diabetic nephropathy in mice by both upregulating NRF2 function via increase in miR-200a and inhibiting miR-21.
    Wu H; Kong L; Tan Y; Epstein PN; Zeng J; Gu J; Liang G; Kong M; Chen X; Miao L; Cai L
    Diabetologia; 2016 Jul; 59(7):1558-1568. PubMed ID: 27115417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-200a in bone marrow mesenchymal stem cells enhances the repair of spinal cord injury in rats by reducing oxidative stress and regulating Keap1/Nrf2 pathway.
    Wang X; Ye L; Zhang K; Gao L; Xiao J; Zhang Y
    Artif Organs; 2020 Jul; 44(7):744-752. PubMed ID: 31995644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-200a attenuated oxidative stress, inflammation, and apoptosis in dextran sulfate sodium-induced colitis through activation of Nrf2.
    Peng S; Shen L; Yu X; Wu J; Zha L; Xia Y; Luo H
    Front Immunol; 2023; 14():1196065. PubMed ID: 37646040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma.
    Wu Z; Zhou L; Ding G; Cao L
    Cancer Biomark; 2017; 18(1):35-39. PubMed ID: 27814273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polydatin prevents fructose-induced liver inflammation and lipid deposition through increasing miR-200a to regulate Keap1/Nrf2 pathway.
    Zhao XJ; Yu HW; Yang YZ; Wu WY; Chen TY; Jia KK; Kang LL; Jiao RQ; Kong LD
    Redox Biol; 2018 Sep; 18():124-137. PubMed ID: 30014902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldose reductase regulates miR-200a-3p/141-3p to coordinate Keap1-Nrf2, Tgfβ1/2, and Zeb1/2 signaling in renal mesangial cells and the renal cortex of diabetic mice.
    Wei J; Zhang Y; Luo Y; Wang Z; Bi S; Song D; Dai Y; Wang T; Qiu L; Wen L; Yuan L; Yang JY
    Free Radic Biol Med; 2014 Feb; 67():91-102. PubMed ID: 24161443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keap1-Nrf2 signalling in pancreatic cancer.
    Hayes AJ; Skouras C; Haugk B; Charnley RM
    Int J Biochem Cell Biol; 2015 Aug; 65():288-99. PubMed ID: 26117456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-200a represses myocardial infarction-related cell death and inflammation by targeting the Keap1/Nrf2 and β-catenin pathways.
    Ma Y; Pan C; Tang X; Zhang M; Shi H; Wang T; Zhang Y
    Hellenic J Cardiol; 2021; 62(2):139-148. PubMed ID: 33197602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
    Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
    Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Akdemir B; Nakajima Y; Inazawa J; Inoue J
    Mol Cancer Res; 2017 Nov; 15(11):1570-1578. PubMed ID: 28760781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.
    Li A; Omura N; Hong SM; Vincent A; Walter K; Griffith M; Borges M; Goggins M
    Cancer Res; 2010 Jul; 70(13):5226-37. PubMed ID: 20551052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WIPF1 antagonizes the tumor suppressive effect of miR-141/200c and is associated with poor survival in patients with PDAC.
    Pan Y; Lu F; Xiong P; Pan M; Zhang Z; Lin X; Pan M; Huang H
    J Exp Clin Cancer Res; 2018 Jul; 37(1):167. PubMed ID: 30041660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.